Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

29.45

-0.15 (-0.51%)

At close: Dec 5, 2025, 4:00 PM EST

29.15

-0.30 (-1.02%)

After-hours: Dec 5, 2025, 5:58 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
Novel Therapeutics	7.02M	Log In	Log In	Log In	Log In	Upgrade
Novel Therapeutics Growth	1.99%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2003 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2003 - 2019
United States	7.02M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	1.99%	Log In	Log In	Log In	Log In	Upgrade